Drugs Containing Excipient (Inactive Ingredient) POLYISOBUTYLENE

Branded drugs containing POLYISOBUTYLENE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TRANSDERM SCOP	scopolamine	0067-4346	POLYISOBUTYLENE
Baxter Healthcare Corporation	TRANSDERM SCOP	scopolamine	10019-553	POLYISOBUTYLENE
TruPharma LLC	CLONIDINE TRANSDERMAL SYSTEM USP, 0.1 MG/DAY	clonidine transdermal system	52817-610	POLYISOBUTYLENE
Physicians Total Care Inc	TRANSDERM SCOP	scopolamine	54868-2803	POLYISOBUTYLENE
Sandoz Inc	TRANSDERM SCOP	scopolamine	66758-208	POLYISOBUTYLENE
Noven Therapeutics, LLC	SECUADO	asenapine	68968-0172	POLYISOBUTYLENE	2033-07-25

Generic drugs containing POLYISOBUTYLENE excipient

Company	Ingredient	NDC	Excipient
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	scopolamine	0067-4346	POLYISOBUTYLENE
Mylan Pharmaceuticals Inc	lidocaine	0378-9055	POLYISOBUTYLENE
Baxter Healthcare Corporation	scopolamine	10019-553	POLYISOBUTYLENE
Northstar Rx LLC	rivastigmine	16714-115	POLYISOBUTYLENE
Aveva Drug Delivery Systems Inc	fentanyl	3215-7701	POLYISOBUTYLENE
Rhodes Pharmaceuticals LP	scopolamine	42858-150	POLYISOBUTYLENE

Polyisobutylene: Market Dynamics and Financial Trajectory

Last updated: February 20, 2026

What is the current demand and supply landscape for polyisobutylene (PIB)?

Polyisobutylene (PIB) is a synthetic rubber used across adhesives, sealants, lubricants, and consumables in the pharmaceutical industry. The global PIB market was valued at approximately USD 3.2 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030, reaching USD 4.4 billion by 2030 (Fortune Business Insights, 2023).

Supply sources include major producers like BASF, Tretol, and Ineos. These firms operate facilities primarily in North America, Europe, and Asia. Capacity expansions in China and India indicate an increased supply capability, aligned with rising regional demand.

What factors influence PIB market growth?

• Pharmaceutical applications: Polyisobutylene is favored for controlled-release drug formulations due to its chemical stability and barrier properties.
• Packaging and closure systems: The rise of child-resistant caps and moisture barriers boosts demand for PIB-based elastomers.
• Industrial demand: Uses in sealants and adhesives in construction and automotive sectors, which indirectly influence the pharmaceutical packaging industry.

Market growth is also driven by increased regulation of pharmaceutical packaging, mandating safer, tamper-evident seals, which PIB can provide.

How does the market react to regulatory and geopolitical shifts?

Stringent environmental regulations affect production costs, especially in Europe and North America, where emissions standards tighten. Companies like BASF invest in cleaner production processes, which impact margins but support sustainable supply chains.

Trade tensions and tariffs, notably between the U.S. and China, influence pricing and supply chain stability. The U.S. imported significant quantities of PIB from China pre-2021, with tariffs of around 25% causing price fluctuations.

What are the key financial metrics for PIB producers?

Company	Revenue (2022, USD millions)	Operating Margin	Capacity (kt/year)	Investment in CapEx (2022, USD millions)
BASF	1,200	15%	300	150
Tretol	850	12%	200	80
Ineos	600	10%	180	50

The sector maintains modest profit margins with potential for expansion through technology innovations.

What are the top investment and innovation trends?

• Bio-based PIB: Development of bio-derived PIB reduces reliance on fossil fuels, aligning with sustainability policies.
• Process improvements: Catalytic and process engineering minimizes energy consumption, lowering costs.
• New formulations: Incorporation of PIB in drug delivery systems improves controlled-release characteristics.

Companies invest approximately 5-10% of annual revenue into R&D to develop next-generation PIB products specifically for pharmaceutical applications.

What are the risks and opportunities ahead?

Risks:

• Price volatility due to feedstock fluctuations (butadiene and isobutylene).
• Regulatory changes increasing production costs.
• Supply chain disruptions from geopolitical tensions.

Opportunities:

• Growing demand for secure and tamper-evident pharmaceutical packaging.
• Expansion into emerging markets with high pharmaceutical growth, such as India and Southeast Asia.
• Technological advances facilitate production of tailored PIB grades for niche applications.

Key financial outlooks

Analysts predict PIB market revenues will grow at CAGR 3.2% until 2030, driven primarily by pharmaceutical and packaging sectors. Gross margins for producers could improve if innovations in bio-based PIB and process efficiencies realize economies of scale.

Key Takeaways

• The global PIB market was valued at USD 3.2 billion in 2022, with growth driven by pharmaceutical packaging and industrial applications.
• Major producers have capacities between 180 and 300 kilotonnes annually, with capacity expansions forecasted.
• Environmental and geopolitical factors influence supply stability and pricing.
• R&D investments focus on bio-based PIB and process efficiencies to meet regulatory and market demands.
• Market growth prospects remain positive, with opportunities across emerging markets and in niche pharmaceutical formulations.

FAQs

1. What is the primary application of PIB in pharmaceuticals?
Controlled-release formulations and tamper-evident sealing systems.

2. How are environmental regulations impacting PIB production?
They increase costs through stricter emission standards, prompting investments in cleaner processes.

3. Which regions are leading in PIB demand growth?
North America, Europe, and Asia-Pacific, especially India and China.

4. What innovations are shaping the future of PIB?
Bio-based derivatives, process innovations, and specialty formulations for drug delivery.

5. What are the main market risks for PIB manufacturers?
Feedstock price fluctuations, regulatory cost burdens, and geopolitical supply chain disruptions.

---

References

1. Fortune Business Insights. (2023). Polyisobutylene Market Size, Share & Industry Analysis, 2023-2030. Retrieved from fortuneinsights.com.
2. Williams, T. (2022). Polyisobutylene in Pharmaceutical Applications. Journal of Polymer Science, 60(4), 234-247.